48Hour Discovery and Quantum Intelligence Corp Join Forces to Form Quantum Intelligence Discovery (QID) – An AI-Powered Drug Discovery Venture

January 13, 2021 | | Uncategorized |

EDMONTON, Alberta–(BUSINESS WIRE)–48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called Quantum Intelligence Discovery. This joint venture between the two start-ups is expected to establish a promising and advanced drug discovery...

Read More

Nova Cell Technology signs a joint research and technology transfer option contract with Canada’s 48Hour Discovery Inc.

January 4, 2021 | | Uncategorized |

(From the PharmNews website of the Korean Business Journal. 출처 : 팜뉴스http://www.pharmnews.com) Novacell Technology Co., Ltd. (Novacell), a Korean biotechnology company that develops peptide immunotherapy, as an affiliate of Donggu Biopharmaceutical, a pharmaceutical/bio-specialized company, and  48 Hour Discovery Inc., (48HD), a Canadian biopharmaceutical...

Read More

Precision Therapeutics’ subsidiary TumorGenesis and its partner 48Hour Discovery Inc. receive Alberta Innovates Product Demonstration Program grant to support development of novel cancer treatments

April 16, 2019 | | Uncategorized |

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) – Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD),...

Read More